Up-regulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity: Troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice

Endocrinology

Volumn 141, Issue 11, 2000, Pages 4021-4031

  Memon, R A ^a   Tecott, L H ^a   Nonogaki, K ^a   Beigneux, A ^a   Moser, A H ^a   Grunfeld, C ^a   Feingold, K R ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; FATTY ACID; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR SUBUNIT; TRIACYLGLYCEROL; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADOLESCENT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENERGY BALANCE; LIPID METABOLISM; LIVER CELL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; STRAIN DIFFERENCE; TISSUE SPECIFICITY;

EID: 0033695790     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.11.7771     Document Type: Article

References (40)

1. The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
2. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
3. Differential expression of Peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β and -γ in the adult rat
4. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver
5. Differential expression of the peroxisome proliferator-activated receptor γ (PPAR γ) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon and breast of the mouse
6. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
7. Altered constitutive expression of fatty acid metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor-α (PPAR-α)
8. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor-α deficient mice
9. PPAR-γ adipogenic regulator and thiazolidinedione receptor
10. The nuclear receptor PPAR-γ: Bigger than fat
11. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
12. Increased peroxisomal fatty acid β-oxidation and enhanced expression of peroxisome proliferator-activated receptor-α in diabetic rat liver
13. Regulation of PPAR-γ gene expression by nutrition and obesity in rodents
14. Tissue distribution and quantitation of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alterations in adipose tissue of obese and NIDDM patients
15. Rosiglitazone (BRL49653), a PPAR-γ selective agonist, causes peroxisome proliferator like liver effects in obese mice
16. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5HT-(2C) receptor gene
17. Eating disorders and epilepsy in mice lacking 5-HT(2C) serotonin receptors
18. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Regulation of putative fatty acid transporters and acyl-CoA synthetase in liver and adipose tissue in ob/ob mice
20. A rapid method of total lipid extraction and purification
21. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion
22. Upregulation of uncoupling protein 2 mRNA in genetic obesity: Lack of an essential role for leptin, hyperphagia, increased tissue lipid content and TNF-α
23. Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration
24. Subcutaneous or visceral adipose tissue expression of the PPARγ gene is not altered in the fatty (fa/fa) Zucker rat
25. Positional cloning of the mouse obese gene and its human homologue
26. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor
27. Troglitazone action is independent of adipose tissue
28. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells
29. The thiazolidmedione insulin sensitizer, BRL49653, increases the expression of PPAR-γ and aP2 in adipose tissue of high-fat fed rats
30. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissue and skeletal muscle
31. Increase in uncoupling protein-2 mRNA expression by BRL49653 and bromopalmitate in human adipocytes
32. Peroxisome proliferator-activated receptors γ and α mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression
33. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes
34. Improved insulin sensitivity in mice heterozygous for PPAR-γ deficiency
35. Physiological properties and functions of intracellular fatty acid binding proteins
36. The uncoupling proteins, a review
37. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm
38. Identification of CD36 (FAT) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
39. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
40. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin